Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Following the approval by the FDA of two COVID-19 vaccines, which are administered in two doses three to four weeks apart, we simulate the effects of various vaccine distribution policies on the cumulative number of infections and deaths in the United States in the presence of shocks to the supply of vaccines. Our forecasts suggest that allocating more than 50% of available doses to individuals who have not received their first dose can significantly increase the number of lives saved and significantly reduce the number of COVID-19 infections. We find that a 50% allocation saves on average 33% more lives, and prevents on average 32% more infections relative to a policy that guarantees a second dose within the recommended time frame to all individuals who have already received their first dose. In fact, in the presence of supply shocks, we find that the former policy would save on average 8, 793 lives and prevents on average 607, 100 infections while the latter policy would save on average 6, 609 lives and prevents on average 460, 743 infections.

Cite

CITATION STYLE

APA

Ben Chaouch, Z., Lo, A. W., & Wong, C. H. (2022). Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals? PLoS ONE, 17(7). https://doi.org/10.1371/journal.pgph.0000498

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free